D A Hudson|M W Smith - JoVE Visualize

Showing results (361-370 of 387) with videos related to

Pageof 39

Sort By:

International Journal of Exercise Science|June 9, 2020

Effect of Acute High-intensity Interval Exercise on Whole-body Fat Oxidation and Subcutaneous Adipose Tissue Cell Signaling in Overweight WomenHashim Islam, Marysa M W Smith, Trisha D Scribbans, et al.

Bio/Technology (Nature Publishing Company)|June 1, 1992

Functional expression of GABAA chloride channels and benzodiazepine binding sites in baculovirus infected insect cellsD B Carter, D R Thomsen, W B Im, et al.

European Journal of Pharmacology|March 19, 1997

Substituted 4-aminopiperidines having high in vitro affinity and selectivity for the cloned human dopamine D4 receptorS K Schlachter, T J Poel, C F Lawson, et al.

Genes and Immunity|April 9, 2005

Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearanceT K Oleksyk, C L Thio, A L Truelove, et al.

Journal of Medicinal Chemistry|April 16, 1993

Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2,3,3a,4,5,9b-hexahydro-1H-benz[e]indole derivativesC H Lin, S R Haadsma-Svensson, R A Lahti, et al.

Journal of Medicinal Chemistry|July 23, 1993

Synthesis and biological activity of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro- 3-propyl-1H-benz[e]indole-9-carboxamide: a potent and selective 5-HT1A receptor agonist with good oral availabilityC H Lin, S R Haadsma-Svensson, G Phillips, et al.

Genomics|September 1, 1993

A sequence-tagged site map of human chromosome 11M W Smith, S P Clark, J S Hutchinson, et al.

Drug Design and Discovery|January 1, 1993

Medicinal chemistry of imidazoquinolinone dopamine receptor agonistsM W Moon, J K Morris, R F Heier, et al.

The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994

Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonistR B McCall, A G Romero, M J Bienkowski, et al.

British Journal of Haematology|June 19, 2001

Polymorphisms in inflammatory cytokines and Fcgamma receptors in childhood chronic immune thrombocytopenic purpura: a pilot studyC B Foster, S Zhu, H C Erichsen, et al.

Pageof 39

Showing results (361-370 of 387) with videos related to

Sort By:

Pageof 39

International Journal of Exercise Science|June 9, 2020

Effect of Acute High-intensity Interval Exercise on Whole-body Fat Oxidation and Subcutaneous Adipose Tissue Cell Signaling in Overweight WomenHashim Islam, Marysa M W Smith, Trisha D Scribbans, et al.

Bio/Technology (Nature Publishing Company)|June 1, 1992

Functional expression of GABAA chloride channels and benzodiazepine binding sites in baculovirus infected insect cellsD B Carter, D R Thomsen, W B Im, et al.

European Journal of Pharmacology|March 19, 1997

Substituted 4-aminopiperidines having high in vitro affinity and selectivity for the cloned human dopamine D4 receptorS K Schlachter, T J Poel, C F Lawson, et al.

Genes and Immunity|April 9, 2005

Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearanceT K Oleksyk, C L Thio, A L Truelove, et al.

Journal of Medicinal Chemistry|April 16, 1993

Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2,3,3a,4,5,9b-hexahydro-1H-benz[e]indole derivativesC H Lin, S R Haadsma-Svensson, R A Lahti, et al.

Journal of Medicinal Chemistry|July 23, 1993

Synthesis and biological activity of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro- 3-propyl-1H-benz[e]indole-9-carboxamide: a potent and selective 5-HT1A receptor agonist with good oral availabilityC H Lin, S R Haadsma-Svensson, G Phillips, et al.

Genomics|September 1, 1993

A sequence-tagged site map of human chromosome 11M W Smith, S P Clark, J S Hutchinson, et al.

Drug Design and Discovery|January 1, 1993

Medicinal chemistry of imidazoquinolinone dopamine receptor agonistsM W Moon, J K Morris, R F Heier, et al.

The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994

Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonistR B McCall, A G Romero, M J Bienkowski, et al.

British Journal of Haematology|June 19, 2001

Polymorphisms in inflammatory cytokines and Fcgamma receptors in childhood chronic immune thrombocytopenic purpura: a pilot studyC B Foster, S Zhu, H C Erichsen, et al.

Pageof 39